Real assets. Real impact. Real ASEAN
Our Projects
Every asset we curate strengthens the backbone of ASEAN with cleaner grids, healthier communities, smarter cities & more connected economies.
OUR ADVANTAGES
1. Local Partnership, Global Access
Invest in ASEAN bridges local governments and global capital, turning Southeast Asia’s infrastructure demand into investable opportunities. Backed by regional partnerships and gov. alignment, every project is anchored in policy certainty, permitting clarity, and regulatory stability. Our relationships across ministries and corporates translate into faster execution, fewer unknowns, and the confidence to deploy capital at scale.
2. Blended Finance, Risk Structure
We specialise in structuring capital where public purpose meets private opportunity. Through concessional finance, guarantees, and FX facilities, we transform early-stage projects into bankable, risk-adjusted investments. Our blended finance approach unlocks institutional participation in sectors once considered too risky delivering long-duration assets aligned with fiduciary standards and global sustainability goals.
3. Stewardship,
Impact
Beyond mobilising capital, we act as long-term stewards of essential infrastructure. Our focus on performance, transparency, and measurable outcomes ensures assets deliver both stable returns and social value. Every investment is designed for resilience advancing carbon reduction, connectivity, and community impact in line with the UN Sustainable Development Goals
The RED Backbone
The world is entering a new
infrastructure super-cycle.
In ASEAN, the RED backbone is reshaping ASEAN economies:
Re-globalisation, Energy transition and Digitalisation (RED)
This is a space to welcome visitors to the site. Grab their attention with copy that clearly states what the site is about, and add an engaging image or video.
Innovative Design
Theme: Re-Globalisation (critical public services)
Vietnam: Fertility Clinics Network
Asset type: Multi-site IVF/ART clinics + shared lab platform (Tier-1 cities)
The aim is to establish a network of world-class artificial intelligence (AI) IVF and reproductive health centres to meet surging regional demand for fertility care. Anchored in major urban centres, the project combines clinical excellence, digital access, and long-term affordability to address Vietnam’s demographic and healthcare transformation.
The platform will operate through public-private partnerships and long-term medical leases, supported by hospital groups and specialist operators. Revenue streams include patient services, diagnostics, and ancillary women’s health programmes, with opportunities for digital expansion and medical tourism.
Structure
The investment is backed by growing policy support for reproductive health and a severe domestic capacity gap. Vietnam currently serves less than half of potential demand. Long-term operating contracts, high asset utilisation, and healthcare resilience make this an attractive, stable-yield health infrastructure play.
Bankability
Initial rollout involves US$20–50 million in development and equipment financing, with blended capital structures involving healthcare operators, DFIs, and institutional investors. Returns are underpinned by 10–13% equity IRR, supported by long-term clinical leases and indexed service contracts.
Returns
This fertility network contributes directly to SDG 3 (Good Health and Well-being), SDG 5 (Gender Equality), and SDG 9 (Industry Innovation) by improving access to reproductive care, supporting women’s health equity, and advancing sustainable healthcare infrastructure.
SDG Alignment
Theme: Energy Transition
Vietnam: Green Hydrogen Hub
Asset type: Renewable-powered electrolysis + ammonia conversion + port logistics
Located in central Vietnam, this project will will develop a 250-400 MW green hydrogen and ammonia facility powered by renewables. The project integrates electrolysis, ammonia conversion and port logistics, positioning Vietnam as a regional clean energy hub.
The project is designed as a 25–30-year BOT/PPP or IPP SPV, backed by long-term take-or-pay contracts for ammonia and hydrogen with indexed floor pricing. Additional upside includes merchant hydrogen for refuelling and contracted O&M, providing stable, inflation-protected returns.
Structure
Supported by Vietnam’s net-zero 2050 target and its emerging hydrogen strategy, Project THANH combines policy alignment, secure offtake, and strategic port access. The proximity to export terminals reduces logistics costs and enables future bunkering pilots, enhancing resilience and revenue diversification.
Bankability
Phase 1 entails a US$200–250 million investment, financed through blended capital: DFI and ECA-backed senior debt, guarantee tranches, and institutional equity. The project targets 12–15% post-wrap equity IRR and a DSCR above 1.35x, with hedging and FX facilities to stabilise returns.
Returns
This project advances SDG 7 (Clean Energy), SDG 9 (Industry Innovation), and SDG 13 (Climate Action). With zero-discharge water loops and CO₂e reporting per tonne of hydrogen, it exemplifies responsible, climate-positive industrialisation that accelerates Vietnam’s green transition and energy security.
SDG Alignment
Theme: Digitisation (biotech knowledge infrastructure)
Vietnam: Viral Vector CDMO
Asset type: GMP-grade viral vector CDMO for lentiviral vectors (LVV)
This will establish Vietnam’s first dedicated CDMO specialising in GMP-grade viral vector manufacturing for gene and cell therapy. Located within an established biomedical cluster, the facility will serve regional and global biotech innovators, bridging R&D, clinical and commercial production gaps in Asia.
The project follows a PPP or joint-venture model with national science and health agencies. It will provide flexible manufacturing suites, enabling small-batch R&D and scale-up to commercial production. Long-term contracts with biotech and pharma clients ensure predictable utilisation and revenues.
Structure
GENESYS aligns with Vietnam’s biotech and pharmaceutical industrialisation roadmap, offering high barriers to entry, export potential, and a diversified client base. Its modular design and global regulatory compliance (GMP, EMA/FDA-ready) position it as a regional innovation asset with durable value.
Bankability
Phase 1 investment of US$15–20 million will be financed through a hybrid structure of equity, concessional debt, and R&D grants. Target equity IRR:
14-16%, supported by anchor client commitments and R&D incentives from government agencies.
Returns
Project GENESYS supports SDG 3 (Health), SDG 8 (Decent Work and Growth), and SDG 9 (Innovation and Infrastructure). It builds Vietnam’s biomedical capacity, fosters regional research collaboration, and advances equitable access to advanced therapeutics across emerging markets.
SDG Alignment
PROJECTS
We are focused on delivering impact across every project, maximising the economical, environmental and social benefit for the long term.